Results 111 to 120 of about 25,074 (200)

Genomic Medicine Sweden: Advancing precision medicine at the national level

open access: yesJournal of Internal Medicine, Volume 300, Issue 4, Page 397-419, October 2026.
Abstract High‐throughput sequencing has transformed clinical diagnostics of rare diseases (RD), cancer and infectious diseases by enabling the identification of disease‐causing genetic alterations and facilitating individualised treatment and care.
Anders Edsjö   +58 more
wiley   +1 more source

Liver and Spleen Stiffness as Non‐Invasive Tools Assessing Liver Congestion in Patients With Budd‐Chiari Syndrome

open access: yesLiver International, Volume 46, Issue 10, October 2026.
ABSTRACT Background and Aims Assessing liver congestion and portal hypertension (PHT) in Budd–Chiari syndrome (BCS) remains challenging. We evaluated liver and spleen stiffness measurements (LSM, SSM) obtained by transient elastography as non‐invasive tools for identifying clinically meaningful liver congestion in BCS.
Andreea Fodor   +22 more
wiley   +1 more source

Clinical management of clonal hematopoiesis

open access: yesCancer, Volume 132, Issue 18, 15 September 2026.
ABSTRACT Clonal hematopoiesis, particularly clonal hematopoiesis of indeterminate potential and clonal cytopenia of undetermined significance, is an age‐related premalignant condition characterized by the expansion of hematopoietic clones carrying somatic mutations.
Kelly S. Chien   +1 more
wiley   +1 more source

COVID-19 in Philadelphia-negative myeloproliferative disorders: a GIMEMA survey. [PDF]

open access: yesLeukemia, 2020
Breccia M   +13 more
europepmc   +1 more source

Analytical cohort study on splenomegaly and cytopenias in myeloproliferative disorders. [PDF]

open access: yesBioinformation
Sinha S   +4 more
europepmc   +1 more source

Myeloproliferative disorders: let the partner guide!

open access: yesHaematologica, 2007
Olivier Rosnet, Daniel Birnbaum
doaj   +1 more source

Home - About - Disclaimer - Privacy